Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How should BRAF V600E-mutated colorectal cancer be treated?

Clinical advances in hematology & oncology : H&O - 1 May 2018

Kopetz Scott

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bevacizumab
Share to Camptothecin
Share to Fluorouracil
Share to Irinotecan

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leucovorin

Share to Organoplatinum Compounds

Share to Oxaliplatin

Share to Randomized Controlled Trials as Topic

Source

Identifiers

PMID: 29851929

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How should BRAF V600E-mutated colorectal cancer be treated?PMID 29851929Read ↗

[Ⅱ.BRAF-Mutated Colorectal Cancer-Up-to-Date Evidence and Clinical Practice].Semantic proximity Read ↗

Colorectal cancer: Targeting BRAF mutations equally?Semantic proximity Read ↗

Treatment of Advanced BRAF-Mutated Colorectal Cancer: Where We Are and Where We Are Going.Semantic proximity Read ↗

Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohort.Semantic proximity Read ↗

Patients with Colorectal Cancer and BRAFV600E-Mutation in Argentina: A Real-World Study: The EMOGI-CRC01 StudySemantic proximity Read ↗

BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?Semantic proximity Read ↗

Colorectal cancer: Overcoming resistance to anti-EGFR therapy - where do we stand?Semantic proximity Read ↗

Colorectal carcinoma: from tumorigenesis to treatmentSemantic proximity Read ↗

Treatment Individualization in Colorectal CancerSemantic proximity Read ↗

Challenges That Hinder the Translation of Clinical Advances Into Practice: Results From an International Assessment in Colorectal Cancer.Semantic proximity Read ↗

How we treat left-sided vs right-sided colon cancer.Semantic proximity Read ↗

How to select the optimal treatment for first line metastatic colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.